And the lemmings continue throwing away their shares. Back in line again for another bite. Without the management changes, this would be back above $2.20. DYOR
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025